Genomas has lead the way to identifying the genetic links to painful side effects associated with statins. (I was honored to have been able to use their gene chip to guide my selection of statins.) This is the right and cost effective way of optimizing drug selection...
"Research by Genomas and collaborators at Hartford Hospital, University of California San Francisco and Yale has demonstrated a strong association between myalgia (muscle pain) arising during statin treatment and variability in genes related to pain perception. The research has been published in the September issue of the leading neurological journal Muscle and Nerve*, published by Wiley InterScience. The findings suggest that serotonergic neurotransmitter receptor function may contribute to the muscle pain induced by statins in some patients inheriting specific variants of the receptor genes. "
For more information go to http://www.genomas.net
"Research by Genomas and collaborators at Hartford Hospital, University of California San Francisco and Yale has demonstrated a strong association between myalgia (muscle pain) arising during statin treatment and variability in genes related to pain perception. The research has been published in the September issue of the leading neurological journal Muscle and Nerve*, published by Wiley InterScience. The findings suggest that serotonergic neurotransmitter receptor function may contribute to the muscle pain induced by statins in some patients inheriting specific variants of the receptor genes. "
For more information go to http://www.genomas.net
